Pharmacokinetics, safety, and efficacy of an alternative dosing regimen of sasanlimab in participants with advanced NSCLC and other malignancies
Penkov, Konstantin, Bondarenko, Igor, Saenko, Daria Viktorovna, Kulyaba, Yaroslav, Guo, Jun, Gong, Yi, Yamamoto, Noboru, Hotko, Yevhen Stepanovych, Boyko, Vasyl, Fadeeva, Natalya Vladimirovna, Ursol, Grygorii Mykolaiovych, Ahn, Hee Kyung, Kislov, Nikolay Viktorovich, Shen, Chia-I, Davis, Craig, Kowalski, Karey, Michelon, Elisabete, Pavlov, Dmitri, Hirohashi, Tomoko, Cho, Byoung Chul
Published in Therapeutic advances in medical oncology (01.01.2024)
Published in Therapeutic advances in medical oncology (01.01.2024)
Get full text
Journal Article
Ataxia and peripheral nerve hypomyelination in ADAM22-deficient mice
Sagane, Koji, Hayakawa, Kazuhiro, Kai, Junko, Hirohashi, Tomoko, Takahashi, Eiki, Miyamoto, Norimasa, Ino, Mitsuhiro, Oki, Tohru, Yamazaki, Kazuto, Nagasu, Takeshi
Published in BMC neuroscience (06.05.2005)
Published in BMC neuroscience (06.05.2005)
Get full text
Journal Article
Characterization of inducible nature of MRP3 in rat liver
Ogawa, K, Suzuki, H, Hirohashi, T, Ishikawa, T, Meier, P J, Hirose, K, Akizawa, T, Yoshioka, M, Sugiyama, Y
Published in American journal of physiology: Gastrointestinal and liver physiology (01.03.2000)
Published in American journal of physiology: Gastrointestinal and liver physiology (01.03.2000)
Get full text
Journal Article
Hepatic Expression of Multidrug Resistance-Associated Protein-Like Proteins Maintained in Eisai Hyperbilirubinemic Rats
Hirohashi, T, Suzuki, H, Ito, K, Ogawa, K, Kume, K, Shimizu, T, Sugiyama, Y
Published in Molecular pharmacology (01.06.1998)
Get full text
Published in Molecular pharmacology (01.06.1998)
Journal Article
Involvement of an Organic Anion Transporter (Canalicular Multispecific Organic Anion Transporter/Multidrug Resistance-Associated Protein 2) in Gastrointestinal Secretion of Glutathione Conjugates in Rats
Gotoh, Y, Suzuki, H, Kinoshita, S, Hirohashi, T, Kato, Y, Sugiyama, Y
Published in The Journal of pharmacology and experimental therapeutics (01.01.2000)
Get full text
Published in The Journal of pharmacology and experimental therapeutics (01.01.2000)
Journal Article
Chronic intracerebroventricular administration of relaxin-3 increases body weight in rats
Hida, Takayuki, Takahashi, Eiki, Shikata, Kodo, Hirohashi, Tomoko, Sawai, Toru, Seiki, Takashi, Tanaka, Hirokazu, Kawai, Takatoshi, Ito, Osamu, Arai, Toru, Yokoi, Akira, Hirakawa, Tetsuya, Ogura, Hiroo, Nagasu, Takeshi, Miyamoto, Norimasa, Kuromitsu, Junro
Published in Journal of receptors and signal transduction (2006)
Published in Journal of receptors and signal transduction (2006)
Get more information
Journal Article
Trials in progress: TAM kinase inhibitor PF-07265807 and sasanlimab plus axitinib in patients with advanced or metastatic renal cell carcinoma—A phase 1, open-label, pharmacokinetic, safety and tolerability study
Hirohashi, Tomoko, Beck, Joseph Thaddeus, McDermott, Jessica Dreger, Abbruzzese, James L., Doi, Toshihiko, Ingram, Kim, Li, Ruifeng, Subbiah, Vivek
Published in Journal of clinical oncology (20.02.2023)
Published in Journal of clinical oncology (20.02.2023)
Get full text
Journal Article
Trials in progress: A phase 1, open-label, pharmacokinetic, safety and tolerability study of PF-07265807 (selective TAM kinase inhibitor) alone or with sasanlimab in patients with advanced or metastatic solid tumors
McDermott, Jessica Dreger, Subbiah, Vivek, Beck, Joseph Thaddeus, Doi, Toshihiko, Hirohashi, Tomoko, Ingram, Kim, Li, Ruifeng, Abbruzzese, James L.
Published in Journal of clinical oncology (01.02.2023)
Published in Journal of clinical oncology (01.02.2023)
Get full text
Journal Article
Trials in progress: A phase 1, open-label, dose-escalation, pharmacokinetic, safety and tolerability study of the selective TAM kinase inhibitor PF-07265807 in patients with advanced or metastatic solid tumors
Subbiah, Vivek, Awad, Mark M., Daud, Adil, Gutierrez, Martin, McDermott, Jessica Dreger, Ou, Sai-Hong Ignatius, Hirohashi, Tomoko, Ingram, Kim, Oliver, Colleen, Smith, Derek, Wollenberg, Lance, Abbruzzese, James L.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
A phase I dose escalation study of bosutinib for amyotrophic lateral sclerosis: Induced pluripotent stem cell-based drug repurposing for amyotrophic lateral sclerosis medicine (IDREAM) study
Inoue, Haruhisa, Imamura, Keiko, Izumi, Yuishin, Nagai, Makiko, Nishiyama, Kazutoshi, Watanabe, Yasuhiro, Hanajima, Ritsuko, Egawa, Naohiro, Ayaki, Takashi, Oki, Ryosuke, Fujita, Koji, Morinaga, Akiko, Hirohashi, Tomoko, Fujii, Yosuke, Uozumi, Ryuji, Morita, Satoshi, Takahashi, Ryosuke
Published in Journal of the neurological sciences (01.10.2021)
Published in Journal of the neurological sciences (01.10.2021)
Get full text
Journal Article
Induced pluripotent stem cell–based Drug Repurposing for Amyotrophic lateral sclerosis Medicine (iDReAM) study: protocol for a phase I dose escalation study of bosutinib for amyotrophic lateral sclerosis patients
Imamura, Keiko, Izumi, Yuishin, Banno, Haruhiko, Uozumi, Ryuji, Morita, Satoshi, Egawa, Naohiro, Ayaki, Takashi, Nagai, Makiko, Nishiyama, Kazutoshi, Watanabe, Yasuhiro, Hanajima, Ritsuko, Oki, Ryosuke, Fujita, Koji, Takahashi, Naoto, Ikeda, Takafumi, Shimizu, Akira, Morinaga, Akiko, Hirohashi, Tomoko, Fujii, Yosuke, Takahashi, Ryosuke, Inoue, Haruhisa
Published in BMJ open (02.12.2019)
Published in BMJ open (02.12.2019)
Get full text
Journal Article
cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3) 1
Kiuchi, Yuichi, Suzuki, Hiroshi, Hirohashi, Tomoko, Tyson, Charles A, Sugiyama, Yuichi
Published in FEBS letters (14.08.1998)
Published in FEBS letters (14.08.1998)
Get full text
Journal Article
Safety and tolerability of bosutinib in patients with amyotrophic lateral sclerosis (iDReAM study): A multicentre, open-label, dose-escalation phase 1 trial
Imamura, Keiko, Izumi, Yuishin, Nagai, Makiko, Nishiyama, Kazutoshi, Watanabe, Yasuhiro, Hanajima, Ritsuko, Egawa, Naohiro, Ayaki, Takashi, Oki, Ryosuke, Fujita, Koji, Uozumi, Ryuji, Morinaga, Akiko, Hirohashi, Tomoko, Fujii, Yosuke, Yamamoto, Takuya, Tatebe, Harutsugu, Tokuda, Takahiko, Takahashi, Naoto, Morita, Satoshi, Takahashi, Ryosuke, Inoue, Haruhisa
Published in EClinicalMedicine (01.11.2022)
Published in EClinicalMedicine (01.11.2022)
Get full text
Journal Article
(9S)-9-(2-hydroxy-4,4-dimethyl-6-oxo-1-cyclohexen-1-yl)-3,3-dimethyl-2,3,4,9-tetrahydro-1H-xanthen-1-one, a selective and orally active neuropeptide YY5 receptor antagonist
Sato, Nagaaki, Jitsuoka, Makoto, Shibata, Takunobu, Hirohashi, Tomoko, Nonoshita, Katsumasa, Moriya, Minoru, Haga, Yuji, Sakuraba, Aya, Ando, Makoto, Ohe, Tomoyuki, Iwaasa, Hisashi, Gomori, Akira, Ishihara, Akane, Kanatani, Akio, Fukami, Takehiro
Published in Journal of medicinal chemistry (14.08.2008)
Published in Journal of medicinal chemistry (14.08.2008)
Get full text
Journal Article
Phase I study (A8471004) in Asian patients of PF-03446962, a fully human mab against ALK-1 receptor involved in tumor angiogenesis: Safety, pharmacokinetics (PK), and pharmacodynamics (PD)
Lee, Kyung-Hun, Doi, Toshihiko, Kim, Tae Min, Ohtsu, Atsushi, Kim, Tae Yong, Ikeda, Masafumi, Yoh, Kiyotaka, Gallo-Stampino, Corrado, Hirohashi, Tomoko, Suzuki, Akiyuki, Yosuke, Fujii, Bang, Yung-Jue
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article